Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Author:
Sekine Takuya, Perez-Potti AndréORCID, Rivera-Ballesteros Olga, Strålin Kristoffer, Gorin Jean-Baptiste, Olsson Annika, Llewellyn-Lacey Sian, Kamal Habiba, Bogdanovic Gordana, Muschiol Sandra, Wullimann David J., Kammann TobiasORCID, Emgård Johanna, Parrot Tiphaine, Folkesson Elin, Rooyackers Olav, Eriksson Lars I., Sönnerborg Anders, Allander Tobias, Albert Jan, Nielsen MortenORCID, Klingström Jonas, Gredmark-Russ Sara, Björkström Niklas K., Sandberg Johan K.ORCID, Price David A., Ljunggren Hans-Gustaf, Aleman Soo, Buggert MarcusORCID,
Abstract
ABSTRACTSARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.
Publisher
Cold Spring Harbor Laboratory
Reference49 articles.
1. Alshukairi, A.N. , Khalid, I. , Ahmed, W.A. , Dada, A.M. , Bayumi, D.T. , Malic, L.S. , Althawadi, S. , Ignacio, K. , Alsalmi, H.S. , Al-Abdely, H.M. , et al. (2016). Antibody Response and Disease Severity in Healthcare Worker MERS Survivors. Emerg Infect Dis 22. 2. Beigel, J.H. , Tomashek, K.M. , Dodd, L.E. , Mehta, A.K. , Zingman, B.S. , Kalil, A.C. , Hohmann, E. , Chu, H.Y. , Luetkemeyer, A. , Kline, S. , et al. (2020). Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 3. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells 4. Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response 5. Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease;PLoS Pathog,2018
Cited by
105 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|